Reaktionsgleichung
ICC(F)(F)F.ClC1C=CC(CBr)=C(F)C=1.N1C2C(=CC=CN=2)C=C1.COC1C=C2C(=NC=1)NC=C2.CCC1N=C(CC2C=CC(OC)=CC=2)OC1.[Cl:53][C:54]1[CH:83]=[CH:82][C:57]([CH2:58][O:59][C:60]2[C:61]([O:79][CH2:80][CH3:81])=[C:62]([C:66]([C:68]3[C:76]4[C:71](=[N:72][CH:73]=[C:74](OC)[CH:75]=4)[NH:70][CH:69]=3)=O)[CH:63]=[CH:64][CH:65]=2)=[C:56](F)[CH:55]=1>>[Cl:53][C:54]1[CH:55]=[CH:56][C:57]([CH2:58][O:59][C:60]2[C:61]([O:79][CH2:80][CH3:81])=[C:62]([CH:63]=[CH:64][CH:65]=2)[CH2:66][C:68]2[C:76]3[C:71](=[N:72][CH:73]=[CH:74][CH:75]=3)[NH:70][CH:69]=2)=[CH:82][CH:83]=1Komponenten
7
Edukt 6
Produkt 1
Versuchsvorschrift
were prepared following the protocol of Scheme 71, substituting iodoethane with iodomethane in Step 3 to provide P-1891, or substituting iodoethane with 2-iodo-1,1,1-trifluoroethane in Step 3 to provide P-2076, or substituting 4-chlorobenzyl bromide 557 with 4-chloro-2-fluoro-benzyl bromide in Step 1 and 7-azaindole 94 with 5-methoxy-7-azaindole in Step 4 to provide P-2016. MS (ESI) [M+H+]+=393.4 (P-1891), 461.08 (P-2076), and 455.2 (P-2016).
Aufarbeitung
- customto provide P-2076
- customto provide P-2016
Quellen und Nachweise
- ORD-Eintrag
- ord-892227a3f33d4c0387bab2c3265cf081
- Quelldatensatz
- uspto-grants-2011_01
- Patentnummer
- US07863288B2
Verknüpfte Notizen
Wird geladen…